Mary Hall is a editor for Investopedia's Advisor Insights, in addition to being the editor of several books and doctoral papers. Mary received her bachelor's in English from Kent State University with ...
Techcyte, developer of the Fusion unified digital pathology platform, and Biobase, creator of an agentic data discovery platform for connecting multi-modal clinical data to pharma and research buyers, ...
March 2026 saw the US Food and Drug Administration grant breakthrough device designation to Path Assist Derm, an artificial ...
Roche RHHBY said Wednesday it will acquire U.S.-based digital pathology and AI company PathAI in a deal worth up to $1.05 ...
EMBED <iframe src="https://archive.org/embed/retro-sample-cds" width="560" height="384" frameborder="0" webkitallowfullscreen="true" mozallowfullscreen="true ...
PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...
PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...
The test imputes risk of metastasis in early-stage hormone receptor-positive, HER2-negative breast cancers to help tailor treatment.
QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...
Waiv will apply its end-to-end computational pathology platform to early phase data, including tumor microenvironment analysis and biomarker discovery.
I have been using the Soft-ECC® sampler for over a decade at different clinical institutions. It reliably picks up ...
The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results